Find News

Filter articles

Showing 131 to 140 of 3302 results

US Congress confirms new drug patent listing law

22-12-2020Muireann Bolger

A $2.3 trillion spending bill passed by the US Congress yesterday, December 21 includes a proposed change to the laws concerning biologic drugs.

Fed Circuit backs Eli Lilly in Apotex’s appeal over failed Alimta NDA

22-12-2020Muireann Bolger

The US Court of Appeals for the Federal Circuit yesterday, December 21, upheld Eli Lilly’s success in barring the sale of a copycat version of cancer treatment Alimta (pemetrexed disodium).

US ITC bars imports of low-cost Botox amid trade secrets dispute

South Korea18-12-2020Legal developments

The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.

Lawyers warn of Irish Sea split over SPCs


The UK is facing a divergence in supplementary protection certificate regulations across the Irish Sea post-Brexit.

Eli Lilly seals $1bn genetics deal

17-12-2020Rory O'Neill

Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

Boston Scientific and Nevro conclude patent dispute

US16-12-2020Sarah Morgan

Medical device company Nevro has agreed to drop a patent infringement suit which accused Boston Scientific of infringing patents related to spinal cord stimulation (SCS) therapy. 

Judge rejects Allergan challenge to FCA suit

US15-12-2020Sarah Morgan

A California judge has allowed a patent attorney to proceed with his claims against Allergan which allege the pharmaceutical company fraudulently obtained patents to monopolise pricing.

AstraZeneca to buy Alexion for $39bn

UK, US14-12-2020Sarah Morgan

AstraZeneca has announced it will acquire Boston-based biopharmaceutical company Alexion Pharmaceuticals, in what is potentially the biggest life sciences deal of this year. 

Amgen faces struggle to revive cholesterol patents, says Fed Circ judge

US14-12-2020Muireann Bolger

Amgen is unlikely to succeed in its bid to revive its patents for the cholesterol drug Repatha, a judge at the US Court of Appeals for the Federal Circuit has told the pharmaceutical company.

90% of essential medicines off-patent, study reveals

International10-12-2020Muireann Bolger

Only 10% of essential medicines recommended by the World Health Organisation are on patent, according to a report by research and advocacy organisation, the Geneva Network.

Showing 131 to 140 of 3302 results